Vladimir Zaharchook
Direttore/Membro del Consiglio presso MEDISTEM INC
Profilo
Vladimir Zaharchook is currently the Vice Chairman at Medistem, Inc. and Director at Nobilis Therapeutics, Inc. He has an undergraduate and graduate degree from Saint Petersburg State University of Economics.
Posizioni attive di Vladimir Zaharchook
| Società | Posizione | Inizio |
|---|---|---|
| MEDISTEM INC | Direttore/Membro del Consiglio | - |
Nobilis Therapeutics, Inc.
 Nobilis Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nobilis Therapeutics, Inc. develops inhalation-based therapeutics for the treatment of neurologic, psychiatric, and development disorders. It develops gas mixtures that offer reproducible, standardized, and controlled patient exposure to address unmet medical needs in psychiatric and neurological disorders, including PTSD, autism, and ADHD. The company was founded by Vlad Bogin and is headquartered in Portland, OR. | Direttore/Membro del Consiglio | - |
Formazione di Vladimir Zaharchook
| Saint Petersburg State University of Economics | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Medistem, Inc.
 Medistem, Inc. Medical SpecialtiesHealth Technology Medistem, Inc. is focused on developing therapies for treating serious diseases and conditions using the natural regenerative properties of stem cells. Endometrial Regenerative Cell possess specialized abilities to stimulate new blood vessel growth and can differentiate into lung, liver, heart, brain, bone, cartilage, fat and pancreatic tissue. The company was founded by Neil H. Riordan in October 2005, and is headquartered in San Diego, CA. | Health Technology |
Nobilis Therapeutics, Inc.
Nobilis Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nobilis Therapeutics, Inc. develops inhalation-based therapeutics for the treatment of neurologic, psychiatric, and development disorders. It develops gas mixtures that offer reproducible, standardized, and controlled patient exposure to address unmet medical needs in psychiatric and neurological disorders, including PTSD, autism, and ADHD. The company was founded by Vlad Bogin and is headquartered in Portland, OR. | Commercial Services |
- Borsa valori
- Insiders
- Vladimir Zaharchook
